Followers | 39 |
Posts | 1624 |
Boards Moderated | 0 |
Alias Born | 04/17/2012 |
Thursday, January 08, 2015 1:47:40 PM
Appreciate all of your thoughts and taking the time to express them.
I will tell you that while I'm not a fan of a RS as a practical matter, I believe the end justifies the means in this case. If done solely for the purpose of gaining a listing on Nasdaq, then the end result in a very positive one for a myriad of reasons.
In today's world, most brokers and fund managers simply can't buy a stock unless it is listed. By not being listed, you unfortunately alienate yourself from virtually 90% of the entire investment community.
This company's fundamentals speak for themselves, the company is actually profitable and demonstrated impressive top line growth for almost 12 consecutive quarters if I recall correctly. The fact that it currently trading at a sub 2X sales multiple really speaks to the value a listing could bring. Virtually no companies that are profitable and growing like this one trade at such a disparate valuation compared to peers.
You have to bear in mind, Meller is the largest shareholder. Therefore, anything he does to all of us, he does to himself to a much greater extent. To do anything that would undermine value creation on the heals of the shares recently hitting highs and just now finally starting to gather a larger investor audience, would defy both reason and his own best interest.
While I too would like to see the RS done at a slightly higher, say 30 plus price, it is neither here nor there in terms of the ultimate big picture in my mind.
The company is evolving from a fundamentals standpoint. The sooner they can better and more appropriately position themselves on an exchange that will allow for that value to be unlocked for shareholders, the better off we all will be.
Thanks again.
Recent SSNT News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/13/2024 09:26:31 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/19/2024 10:27:28 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/16/2024 11:18:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 10:40:25 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 02:57:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/05/2024 10:16:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/28/2023 09:20:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/19/2023 10:13:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:15:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:20:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/14/2023 02:53:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 02:57:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 02:56:37 AM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 12/13/2023 10:23:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/13/2023 03:19:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/12/2023 02:19:07 PM
- Brad Jacobs to Enter Building Products Distribution Industry • GlobeNewswire Inc. • 12/11/2023 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/07/2023 02:59:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 09:19:45 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/04/2023 01:09:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 01:08:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/27/2023 09:53:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:46:25 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM